KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $978590.0.

  • Inovio Pharmaceuticals' Receivables - Net fell 4746.5% to $978590.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $978590.0, marking a year-over-year decrease of 4746.5%. This contributed to the annual value of $1.2 million for FY2024, which is 5014.79% down from last year.
  • Per Inovio Pharmaceuticals' latest filing, its Receivables - Net stood at $978590.0 for Q3 2025, which was down 4746.5% from $840312.0 recorded in Q2 2025.
  • In the past 5 years, Inovio Pharmaceuticals' Receivables - Net registered a high of $13.1 million during Q2 2021, and its lowest value of $73304.0 during Q1 2023.
  • For the 5-year period, Inovio Pharmaceuticals' Receivables - Net averaged around $3.9 million, with its median value being $2.4 million (2022).
  • Its Receivables - Net has fluctuated over the past 5 years, first crashed by 9816.91% in 2023, then surged by 338014.02% in 2024.
  • Over the past 5 years, Inovio Pharmaceuticals' Receivables - Net (Quarter) stood at $5.5 million in 2021, then soared by 83.59% to $10.0 million in 2022, then crashed by 76.04% to $2.4 million in 2023, then tumbled by 50.15% to $1.2 million in 2024, then fell by 18.39% to $978590.0 in 2025.
  • Its last three reported values are $978590.0 in Q3 2025, $840312.0 for Q2 2025, and $1.3 million during Q1 2025.